about
Binding of a designed anti-cancer drug to the central cavity of an RNA three-way junctionColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerGold ion-angiotensin peptide interaction by mass spectrometry.Silver (I) as DNA glue: Ag(+)-mediated guanine pairing revealed by removing Watson-Crick constraintsPolymeric Micelle-Mediated Delivery of DNA-Targeting Organometallic Complexes for Resistant Ovarian Cancer Treatment.Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.Targeted and multifunctional arene ruthenium chemotherapeutics.Copper complexes as therapeutic agents.Ruthenium complexes as antimicrobial agents.In Vitro DNA-Binding, Anti-Oxidant and Anticancer Activity of Indole-2-Carboxylic Acid Dinuclear Copper(II) Complexes.In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.New palladium(II) and platinum(II) 5,5-diethylbarbiturate complexes with 2-phenylpyridine, 2,2'-bipyridine and 2,2'-dipyridylamine: synthesis, structures, DNA binding, molecular docking, cellular uptake, antioxidant activity and cytotoxicity.Highly cytotoxic DNA-interacting copper(II) coordination compounds.Potent organometallic osmium compounds induce mitochondria-mediated apoptosis and S-phase cell cycle arrest in A549 non-small cell lung cancer cells.Alterations of phosphoproteins in NCI-H526 small cell lung cancer cells involved in cytotoxicity of cisplatin and titanocene Y.Pharmacological classification and activity evaluation of furan and thiophene amide derivatives applying semi-empirical ab initio molecular modeling methods.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.Metal to ligand charge transfer induced DNA photobinding in a Ru(II)-Pt(II) supramolecule using red light in the therapeutic window: a new mechanism for DNA modification.The antimicrobial properties of some copper(II) and platinum(II) 1,10-phenanthroline complexes.Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy.Novel Oligopyrrole Carboxamide based Nickel(II) and Palladium(II) Salens, Their Targeting of Human G-Quadruplex DNA, and Selective Cancer Cell Toxicity.Acetyl pyridine-based palladium(II) compounds as an artificial metallonucleases.Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural FactorIsatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors
P2860
Q27686681-F927BEC6-9309-4213-AC5B-F9409C2411B0Q30238915-23953161-2217-497C-B454-14D9C0F6F5D5Q34164962-CB5DD3E2-0C55-418D-91B0-C9A020D45B34Q35605659-0DC88946-ACE4-4EE7-912D-525893918BB9Q36253687-F3F4B10E-2DA0-4BCB-8397-61B988C4E2E2Q36942237-4B0C77D8-6B15-410F-94C6-412A69BD9C21Q36952837-CB8928CA-EB64-4326-B25B-7E9EDF413749Q37263372-3D33DFC8-E328-481E-91B9-9A43AA372A15Q37920741-DAA1CCD3-528A-4419-9A79-F49DD014655BQ37970312-191966FC-3390-455F-9284-BC9A3FA77CDDQ38365877-210DA122-AB4A-4607-9987-27F5E3568A91Q38719744-5C5011AC-2C84-470A-8B3D-84212EEA2DF5Q38827745-1E2A890B-25FD-492C-A71D-3C673B23A29EQ38899965-133F21AC-9B6C-49EE-B3EB-7B36B2487DA0Q38968421-FCFD68E6-2F82-4D37-B388-1CCFC5AC9346Q39011794-E475521D-84A4-41C1-B8D5-3089796138E9Q39270001-A7F60F4C-B3A0-4164-82FA-FABF8BAF2A0FQ39307423-06B2B3E3-716A-40B8-8058-F3297090A3FAQ39400527-2C3E6232-13B1-4C67-BC51-D9C6327F3FC7Q42400560-F3E4AC0A-6106-46D7-A04C-A91BA2016942Q44970611-215DFCE8-A455-414E-B06E-B54C0E4C9CDEQ45246286-D9A82483-1BA5-4E04-A25D-1BDF5A865637Q48368172-99E25F4C-04CB-4AC9-B3AE-CF87A5F0E978Q49061522-ECB3C17D-D295-43E8-9FCD-FA7EF9AF21D4Q52925029-731D5162-16B9-42C9-88CE-6CDC4EFFDBECQ53134492-5C73B00C-94EB-4C68-B03F-D8FDFF1BD31EQ58993871-4439CA08-E805-480E-B2B4-86ED2A36F5ECQ59136768-F397DE9C-2B4A-4706-8D19-378708CDAA66
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transition metal based anticancer drugs.
@en
Transition metal based anticancer drugs.
@nl
type
label
Transition metal based anticancer drugs.
@en
Transition metal based anticancer drugs.
@nl
prefLabel
Transition metal based anticancer drugs.
@en
Transition metal based anticancer drugs.
@nl
P2093
P50
P1476
Transition metal based anticancer drugs
@en
P2093
Benjamin W Harper
K Benjamin Garbutcheon-Singh
Maxine P Grant
Nikita Orkey
P304
P356
10.2174/156802611794785226
P577
2011-01-01T00:00:00Z